CVLLY (CellaVision AB) E10: $0.31 (As of Mar. 2026)


CVLLY CellaVision AB CVLLY
69 GF Score
Price $7.06
GF Value $12.48
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is CellaVision AB E10?

CellaVision AB CVLLY +12.06% 69 E10 is $0.31 as of Mar. 2026. GuruFocus rates CVLLY with a GF Score™ of 69/100 and a GF Value™ of $12.48 (Significantly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

CellaVision AB's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.31 for the trailing ten years ended in Mar. 2026.

During the past 12 months, CellaVision AB's average E10 Growth Rate was 5.70% per year. During the past 3 years, the average E10 Growth Rate was 11.50% per year. During the past 5 years, the average E10 Growth Rate was 17.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of CellaVision AB was 22.10% per year. The lowest was 11.50% per year. And the median was 17.40% per year.

As of today (2026-06-24), CellaVision AB's current stock price is $7.06. CellaVision AB's E10 for the quarter that ended in Mar. 2026 was $0.31. CellaVision AB's Shiller PE Ratio of today is 22.77.

During the past 13 years, the highest Shiller PE Ratio of CellaVision AB was 184.21. The lowest was 22.81. And the median was 101.63.


CellaVision AB  (OTCPK:CVLLY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CellaVision AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=7.06/0.31
=22.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of CellaVision AB was 184.21. The lowest was 22.81. And the median was 101.63.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


CellaVision AB E10 Related Terms


CellaVision AB E10 Historical Data

* Premium members only.

The historical data trend for CellaVision AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellaVision AB E10 Chart

CellaVision AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CellaVision AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.31

CVLLY vs ABT, SYK, MDT: E10 Comparison

For the Medical Devices subindustry, CellaVision AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellaVision AB Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CellaVision AB's Shiller PE Ratio falls into.


CVLLY
69GF Score
CellaVision AB CVLLY
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellaVision AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CellaVision AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.05/133.3862*133.3862
=0.050

Current CPI (Mar. 2026) = 133.3862.

CellaVision AB Quarterly Data

per share eps CPI Adj_EPS
201606 0.043 101.019 0.057
201609 0.038 101.138 0.050
201612 0.041 102.022 0.054
201703 0.059 102.022 0.077
201706 0.047 102.752 0.061
201709 0.020 103.279 0.026
201712 0.043 103.793 0.055
201803 0.049 103.962 0.063
201806 0.056 104.875 0.071
201809 0.039 105.679 0.049
201812 0.069 105.912 0.087
201903 0.062 105.886 0.078
201906 0.067 106.742 0.084
201909 0.037 107.214 0.046
201912 0.054 107.766 0.067
202003 0.043 106.563 0.054
202006 0.061 107.498 0.076
202009 0.032 107.635 0.040
202012 0.072 108.296 0.089
202103 0.070 108.360 0.086
202106 0.077 108.928 0.094
202109 0.063 110.338 0.076
202112 0.091 112.486 0.108
202203 0.084 114.825 0.098
202206 0.078 118.384 0.088
202209 0.020 122.296 0.022
202212 0.065 126.365 0.069
202303 0.039 127.042 0.041
202306 0.068 129.407 0.070
202309 0.049 130.224 0.050
202312 0.103 131.912 0.104
202403 0.061 132.205 0.062
202406 0.077 132.716 0.077
202409 0.064 132.304 0.065
202412 0.078 132.987 0.078
202503 0.086 132.825 0.086
202506 0.083 133.699 0.083
202509 0.070 133.482 0.070
202512 0.096 133.386 0.096
202603 0.050 133.386 0.050

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.31 mean?
CellaVision AB (CVLLY) has a E10 of $0.31 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on CellaVision AB and its competitors.
Is CellaVision AB's E10 too high?
CellaVision AB's current E10 is $0.31. Overall, CellaVision AB has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CellaVision AB's E10 compare to ABT and SYK?
CellaVision AB's E10 of $0.31 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on CellaVision AB and its competitors. CellaVision AB's current E10 is $0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellaVision AB stock overvalued right now?
Based on GuruFocus' analysis, CellaVision AB (CVLLY) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.48, compared to a current price of $7.06 — trading 43.4% below its estimated fair value. The current E10 is $0.31. CellaVision AB's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For CellaVision AB (CVLLY), the current E10 is $0.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellaVision AB (CVLLY) Overvalued in 2026?

Based on GuruFocus' analysis, CellaVision AB stock appears to be undervalued. The current stock price of $7.06 is trading 43.4% below its estimated GF Value™ of $12.48. GuruFocus considers CellaVision AB to be Significantly Undervalued.

Key valuation signals for CVLLY:

  • E10: $0.31
  • GF Value™: $12.48 vs. price of $7.06 (43.4% below fair value)
  • GF Score™: 69/100 with 1 warning sign

No single metric tells the full story. See the CVLLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CellaVision AB Business Description

Address Mobilvagen 12, Lund, SWE, 22362
CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.
69GF Score

Get the complete analysis for CVLLY

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.06
Price
$12.48
GF Value